Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice.

Bao L, Haas M, Kraus DM, Hack BK, Rakstang JK, Holers VM, Quigg RJ. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. J Am Soc Nephrol. 2003 Mar; 14(3):670-9.

View in: PubMed

collapse authors with profiles